Kimia Biosciences Limited (BOM:530313)

India · Delayed Price · Currency is INR

37.99

+1.64 (4.51%)

At close: May 8, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Pharmaceuticals	1.19B	1.05B	1.29B	1.25B	1.33B
Pharmaceuticals Growth	13.39%	-18.39%	2.89%	-5.89%	24.86%
Total	1.19B	1.05B	1.29B	1.25B	1.33B
Total Growth	13.39%	-18.39%	2.89%	-5.89%	24.86%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
India	967.92M	777.16M	1.03B	1.02B	1.18B
India Growth	24.54%	-24.84%	1.49%	-13.59%	16.01%
outside India	216.52M	266.28M	247.40M	227.47M	143.70M
outside India Growth	-18.69%	7.63%	8.76%	58.29%	221.48%
Total	1.18B	1.04B	1.28B	1.25B	1.32B
Total Growth	13.51%	-18.57%	2.82%	-5.78%	24.66%

Source: S&P Global Market Intelligence.